Notably, bromodomain PHD-finger TF (BPTF) is an attractive target for certain cancers, considerably correlating with the expression levels of EMT markers (Vimentin and E-cadherin), which can promote EMT progression in CRC [84]. This evidence concerns the gene BPTF and cancer.